Document Detail


Butyric acid increases invasiveness of HL-60 leukemia cells: role of reactive oxygen species.
MedLine Citation:
PMID:  11997038     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Butyric acid (BA) induces differentiation of human leukemia, including HL-60 cells. By using a fluorescent probe, we showed that reactive oxygen species (ROS) were generated in BA-treated cells. BA-induced differentiation was accompanied with an increased secretion of pro-matrix metalloproteinase (MMP)-9. Both phenomena were inhibited by antioxidants. Tissue inhibitors of MMP (TIMP)-1 and -2 secretion were increased by BA, but differently affected by antioxidants. By contrast, BA did not affect MMP-9 mRNA, and decreased TIMP-1 and TIMP-2 mRNA levels. In addition, migratory and invasive properties of HL-60 cells were enhanced by BA, but differently affected by antioxidants. Altogether, these results indicate that ROS are messengers of BA-induced differentiation and increased invasiveness.
Authors:
Doriane Richard; Patrick Hollender; Benoît Chénais
Related Documents :
19002918 - Measurement of oxygen uptake and carbon dioxide production rates ofmammalian cells usin...
25207648 - Acetate and bicarbonate assimilation and metabolite formation in chlamydomonas reinhard...
2813988 - Microcirculation in striated muscle after acute reduction in systemic hematocrit.
10401598 - H2o2 mediates o2 toxicity in cultured fetal rat distal lung epithelial cells.
16674678 - Differentiation of human ameloblast-lineage cells in vitro.
19143028 - Dysplasia of human prostate cd133(hi) sub-population in nod-scids is blocked by c-myc a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  FEBS letters     Volume:  518     ISSN:  0014-5793     ISO Abbreviation:  FEBS Lett.     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-05-08     Completed Date:  2002-05-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0155157     Medline TA:  FEBS Lett     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  159-63     Citation Subset:  IM    
Affiliation:
Unité MéDIAN, CNRS FRE-2141, Université de Reims-Champagne Ardenne, Faculté de Pharmacie, 51 rue Cognacq-Jay, F-51096 Cedex, Reims, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antioxidants / pharmacology
Butyric Acid / antagonists & inhibitors,  pharmacology*
Cell Differentiation / drug effects
Cell Movement*
HL-60 Cells
Humans
Leukemia, Promyelocytic, Acute / enzymology,  metabolism*,  pathology
Matrix Metalloproteinase 9 / biosynthesis,  genetics
Neoplasm Invasiveness
RNA, Neoplasm / biosynthesis
Reactive Oxygen Species / metabolism*
Tissue Inhibitor of Metalloproteinases / biosynthesis
Chemical
Reg. No./Substance:
0/Antioxidants; 0/RNA, Neoplasm; 0/Reactive Oxygen Species; 0/Tissue Inhibitor of Metalloproteinases; 107-92-6/Butyric Acid; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP...
Next Document:  cDNA cloning and characterization of tobacco ABC transporter: NtPDR1 is a novel elicitor-responsive ...